Press Release

Your NEXT Option™
Nov / 2022

Teon Therapeutics Announces First Patient Treated in Phase 1/2 Clinical Trial of TT-816, a Novel Oral Immune Checkpoint Inhibitor, in Patients with Advanced Solid Tumors

Featured image for “Teon Therapeutics Announces First Patient Treated in Phase 1/2 Clinical Trial of TT-816, a Novel Oral Immune Checkpoint Inhibitor, in Patients with Advanced Solid Tumors”
Oct / 2022

The Theresa Mays Endowed Merit Award Established for Promising Investigators Holding a PharmD Degree

Featured image for “The Theresa Mays Endowed Merit Award Established for Promising Investigators Holding a PharmD Degree”
Oct / 2022

NEXT Oncology Selects proXimityTM to Automate Data Transfer for Clinical Trials

Featured image for “NEXT Oncology Selects proXimityTM to Automate Data Transfer for Clinical Trials”
Sep / 2022

NEXT Oncology’s Dr. Anthony Tolcher Presents Data on Well-Tolerated Monotherapy
for Advanced and Metastatic Tumors at ESMO Congress 2022

Featured image for “NEXT Oncology’s Dr. Anthony Tolcher Presents Data on Well-Tolerated Monotherapy<br>for Advanced and Metastatic Tumors at ESMO Congress 2022”
Jun / 2022

Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial

Featured image for “Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial”
Jun / 2022

 NEXT Oncology Gives Patient Her Life Back with Clinical Trials 

Featured image for “ NEXT Oncology Gives Patient Her Life Back with Clinical Trials ”

Request Information From NEXT

We will respond to you with more information soon.
Contact NEXT